Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Stocks on Jim Cramer’s Radar

Page 1 of 9

Jim Cramer, the host of Mad Money, recently shared his outlook for Wall Street, focusing on earnings reports. On Friday, he highlighted how the S&P 500 surged toward 6,000 in almost a straight line, a remarkable rally driven by overwhelming buying and a lack of selling. Cramer noted the market’s performance, pointing out that the Dow rose by 260 points, the S&P gained 0.38%, and the Nasdaq advanced 0.09%, with all major indices closing at new record highs.

He described Friday as another impressive session, adding that it marked a historic moment. Cramer reiterated his point, stating:

“This is ladies and gentlemen, a historic move we are witnessing, fueled by an election where voters chose a candidate who is pro-growth, pro-higher stock prices, pro-lower interest rates, and pro-lower taxes… Trump is the most explicitly pro-stock market president in history.”

READ ALSO Jim Cramer Talked About These 16 Stocks and Jim Cramer Says These 10 Stocks Can Do Well Regardless of Who Wins

Cramer went on to say that now that Trump has won, the benefits are clear across many sectors. He cited tech, oil, pharmaceuticals, consumer goods, and financials as prime examples of sectors seeing strong performance. He emphasized that these gains were driven by money managers who feared missing out on the market’s upward trajectory and were unwilling to sell, knowing they might not have enough stocks in their portfolios. Cramer also predicted that we would soon witness a surge in mergers and acquisitions.

“At the same time, we’re about to see a wave of takeovers as the antitrust regulators will stop trying to block every deal under the sun because a new broom is gonna sweep clean.”

Cramer stressed the importance of looking at the market on a sector-by-sector basis. He noted that the tech sector had taken a breather on Friday. In the coming days, he suggested that retailers might surge, followed by financials and then industrials. He described this cycle of sector rotations as part of an “incredibly bullish, virtuous circle” of market gains. While Cramer acknowledged that stocks had performed well under President Biden, he pointed out that Biden didn’t seem to place much importance on the stock market during his tenure.

“For him, it was an abstraction,” Cramer remarked, adding that this stance was changing with the current administration. In conclusion, Cramer made it clear that stocks were about to have a true champion in the White House once again.

“Stocks are about to have a champion in the White House again, even if you might think they aren’t worthy of a presidential supporter. I say get used to it, even though the buying’s started already, because we got a lot more room to run.”

10 Stocks on Jim Cramer’s Radar

Our Methodology

For this article, we compiled a list of 10 stocks that were discussed by Jim Cramer during the episode of Mad Money on November 8 and listed the stocks in the order that Cramer mentioned them.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

10 Stocks on Jim Cramer’s Radar

10. Alibaba Group Holding Limited (NYSE:BABA)

Cramer called Alibaba Group Holding Limited (NYSE:BABA) the Amazon of China but did not recommend buying the shares. Here’s what he said:

“Friday morning, Alibaba reports. I’ve been adamant that if you want to invest in China, you need to buy shares of Alibaba because it has Western financials and it’s a legit, monstrous online retailer. We know that the Chinese consumer is hobbled when it comes to luxury goods and there seems to be a sense of listlessness in that populace. That said, Alibaba does a ton of business and makes the numbers pretty routinely. It’s the Amazon of China.

You need to know that I’m not recommending anything in China, not here, not anywhere, because I think the economy is a train wreck there and the government stimulus efforts have proven ineffective, including today’s multi-year, $1.4 trillion local government bailout. Yet another plan that won’t put money in people’s hands. People that are dealing with a deflationary environment, they need to have money, which is so desperately needed if China ever wants to return to growth.”

Alibaba (NYSE:BABA) provides technology infrastructure, marketing services, and e-commerce platforms to help businesses engage with customers across various industries. Chinese authorities have increased stimulus measures since late September. We discussed the factors affecting Chinese stocks, including BABA, in our article, 10 Best Low Volatility Stocks to Invest in Now. Here is an excerpt:

“Two main themes are affecting Chinese stocks such as Alibaba (NYSE:BABA). First, investor wariness stems from the Chinese government’s unpredictable interventions, as seen when Alibaba’s (NYSE:BABA) stock dropped from around $350 to under $100 after regulatory actions three years ago. Second, U.S.-China tensions add pressure, with tariffs and tech restrictions slowing China’s economy, casting doubt on reported growth rates.”

On Friday, China unveiled a major financial initiative, a five-year plan worth 10 trillion yuan (approximately $1.4 trillion), aimed at addressing local government debt challenges. The announcement was made by Minister of Finance Lan Fo’an, who shared that the government would actively utilize available fiscal space, with plans to expand the deficit in the coming year.

The goal of these measures is to assist local governments in reducing what is known as “hidden debt”. As per Lan’s comments, this hidden debt is expected to decrease significantly, from an estimated 14.3 trillion yuan at the close of 2023 to just 2.3 trillion yuan by 2028.

9. Applied Materials, Inc. (NASDAQ:AMAT)

Cramer mentioned that the semiconductor stocks have recently suffered because of the ASML debacle and expressed hope that Applied Materials, Inc.’s (NASDAQ:AMAT) earnings will change the narrative.

“Thursday after the close, we have results from Applied Materials, AMAT… They’re considered to be the dean of the semiconductor capital equipment industry… Now, I think this group’s been falsely accused of weak demand because of… ASML, which did a real horrible job explaining its story. Hopefully, Applied Materials can clear things up when it reports. The semis have been weak of late… maybe Applied Materials can change that dynamic.”

Applied Materials (NASDAQ:AMAT) provides manufacturing equipment, services, and software to the semiconductor, display, and related industries, offering solutions to improve performance and productivity in chip fabrication, display technologies, and related applications. In October, it experienced a dip in stock price, which was largely attributed to the disappointing quarterly report from ASML, another key player in the semiconductor equipment market.

This news prompted concerns across the market about a potential slowdown in the semiconductor equipment sector, and as a result, Applied Materials saw its stock decline on the same day. However, it is important to note that this decline was driven by broader market sentiment. On November 12, Stifel lowered the price target on Applied Materials (NASDAQ:AMAT) to $250 from $270 and maintained a Buy rating.

Ahead of the company’s fiscal Q4 report, which is set to be released on November 14, Stifel kept its near-term estimates unchanged, expecting the company’s Q4 results and Q1 guidance to meet or modestly exceed both the firm’s and consensus estimates. However, as the company approaches 2025, there is growing attention on the outlook for its revenue from China. Stifel also adjusted its forecasts for calendar year 2025, lowering estimates that were initially based on a higher expectation for wafer fab equipment (WFE) growth.

Page 1 of 9

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

Penicillin Changed the World. This Drug Could Too

This Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses Including a single drug to treat COVID, RSV, FLU and even Monkey-pox!

This is a clinical-stage, global leader in broad-spectrum antiviral nanomedicines who is developing therapeutic drugs that work safely and effectively, even against emerging variants!

A novel broad-spectrum antiviral

NV-387,  a drug that  treats RSV, COVID-19, Long COVID, Influenza, Bird Flu H5N1, and other respiratory viral infections as well as Monkey-pox, has successfully completed Phase 1 clinical trials in healthy subjects with no reported adverse events, even at the highest and repeated dosages. Remarkably, the company has been able to develop NV-387 for oral administration already, as well as for injectable and inhalation formulations to enable many modes of use. The Company is currently focused on advancing NV-387 into Phase II human clinical trials for the treatment of RSV infection.

Susceptible viruses CANNOT escape NV-387, even as they continue to evolve in the field into variants. Why? Because  no matter how much the virus changes, it continues to use the same host-side signature to bind to and cause infection in the hosts, and thus the nanoviricide would be anticipated to continue to be effective even as the virus mutates to generate variants.

Click to continue reading…